Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Heterologous neutralization breadth persists despite B-lymphocyte dysfunction in chronic HIV-1 infection ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Murphy, MK
- Contributor
-
Boliar, S.
Tran, TC
Carnathan, DG
Armstrong, WS
Silvestri, G.
Derdeyn, CA
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P103
- URN
-
urn:nbn:de:1111-2016080727363
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Murphy, MK
- Boliar, S.
- Tran, TC
- Carnathan, DG
- Armstrong, WS
- Silvestri, G.
- Derdeyn, CA
- SpringerLink (Online service)
Other Objects (12)
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
The Neutralization of Egypt.
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen
The Neutralization of Egypt.
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
Patent Breadth in an International Setting
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
Breadth, phenotype and functionality of Gag-specific T cell responses induced by a heterologous DNA/MVA prime-boost HIV-1 vaccine regimen